At a glance
ClinicalIndex Comparison RecordN/ACompleted· 46 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Linking Optic Nerve Lesion Length at MRI and the Retinal Axonal Loss at 12 Months From a Clinical Episode of Optic Neuritis
In Brief
An observational study for Optic Neuritis. Completed, enrolled 46 participants across 1 site.
Detailed Summary
This study evaluates the length of optic nerve lesion on 3D-DIR sequence as an imaging biomarker predictive of retinal axonal loss and visual disability, 12 months after the occurence of a first clinical episode of optic neuritis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOptic Neuritis
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedAug 2018
Primary CompletionMar 2020
TodayJul 2026
First PostedAug 29, 2018
Enrollment StartFeb 1, 2016
Primary CompletionMar 11, 2020
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 7.8 years ago